Toyama T - Search Results

1

Suppression of ING1 expression in sporadic breast cancer.

Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K. Toyama T, et al. Oncogene. 1999 Sep 16;18(37):5187-93. doi: 10.1038/sj.onc.1202905. Oncogene. 1999. PMID: 10498868

2

[Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer].

Iwase H, Kobayashi S, Iwata H, Yamashita T, Ito K, Toyama T, Hara Y, Greenman J, Mathew CG. Iwase H, et al. Among authors: toyama t. Gan To Kagaku Ryoho. 1996 Mar;23 Suppl 1:61-5. Gan To Kagaku Ryoho. 1996. PMID: 8702313 Review. Japanese.

3

Expression of estrogen receptor alpha exon 5 and 7 deletion variant in human breast cancers.

Omoto Y, Iwase H, Iwata H, Hara Y, Toyama T, Ando Y, Kobayashi S. Omoto Y, et al. Among authors: toyama t. Breast Cancer. 2000 Jan;7(1):27-31. doi: 10.1007/BF02967184. Breast Cancer. 2000. PMID: 11029767

4

Clinical significance of AIB1 expression in human breast cancer.

Iwase H, Omoto Y, Toyama T, Yamashita H, Hara Y, Sugiura H, Zhang Z. Iwase H, et al. Among authors: toyama t. Breast Cancer Res Treat. 2003 Aug;80(3):339-45. doi: 10.1023/A:1024916126532. Breast Cancer Res Treat. 2003. PMID: 14503806

5

Decreased expression of p33ING1 mRNA in lymphoid malignancies.

Ohmori M, Nagai M, Tasaka T, Koeffler HP, Toyama T, Riabowol K, Takahara J. Ohmori M, et al. Among authors: toyama t. Am J Hematol. 1999 Oct;62(2):118-9. doi: 10.1002/(sici)1096-8652(199910)62:2<118::aid-ajh11>3.0.co;2-x. Am J Hematol. 1999. PMID: 10577281 Free article.

6

Microsatellite instability in sporadic human breast cancers.

Toyama T, Iwase H, Yamashita H, Iwata H, Yamashita T, Ito K, Hara Y, Suchi M, Kato T, Nakamura T, Kobayashi S. Toyama T, et al. Int J Cancer. 1996 Nov 15;68(4):447-51. doi: 10.1002/(SICI)1097-0215(19961115)68:4<447::AID-IJC8>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8945614 Free article.

7

Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers.

Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Gustafsson JA, Iwase H. Omoto Y, et al. Among authors: toyama t. Eur J Cancer. 2002 Feb;38(3):380-6. doi: 10.1016/s0959-8049(01)00383-5. Eur J Cancer. 2002. PMID: 11818203

8

Clinical significance of bcl-2 gene expression in human breast cancer tissues.

Kobayashi S, Iwase H, Ito Y, Yamashita H, Iwata H, Yamashita T, Ito K, Toyama T, Nakamura T, Masaoka A. Kobayashi S, et al. Among authors: toyama t. Breast Cancer Res Treat. 1997 Jan;42(2):173-81. doi: 10.1023/a:1005760013810. Breast Cancer Res Treat. 1997. PMID: 9138606

9

[Prognostic significance of loss of heterozygosity in breast cancer].

Iwase H, Iwata H, Toyama T, Hara Y, Omoto Y, Kobayashi S. Iwase H, et al. Among authors: toyama t. Gan To Kagaku Ryoho. 1998 Apr;25 Suppl 3:426-30. Gan To Kagaku Ryoho. 1998. PMID: 9589047 Japanese.

10

Comparison of five different antibodies in the immunohistochemical assay of estrogen receptor alpha in human breast cancer.

Kobayashi S, Ito Y, Ando Y, Omoto Y, Toyama T, Iwase H. Kobayashi S, et al. Among authors: toyama t. Breast Cancer. 2000;7(2):136-41. doi: 10.1007/BF02967445. Breast Cancer. 2000. PMID: 11029785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

941 results

Search Page